SANOFI

Anticuerpos biespecíficos contra cd28/ox40

N° CO2025009596A2

Compuestos terapéuticos

N° CO2025009226A2

CRF1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia

N° AU2025205083A1

CD28/OX40 BISPECIFIC ANTIBODIES

N° MX2025007147A

Proteínas de unión al receptor de transferrina

N° CO2025008110A2

TRANSFERRIN RECEPTOR BINDING PROTEINS

N° MX2025006478A

CEACAM5 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

N° MX2025005811A

Ceacam5 antibody-drug conjugates and methods of use thereof

N° IL320894A

Anticuerpos anti-cd28

N° CO2025005325A2

ANTI-GPRC5D ANTIBODIES AND COMPOSITIONS

N° US2025230234A1

Anti-cd28 antibodies

N° IL319891A

ANTI-CD28 ANTIBODIES

N° MX2025003723A

Combination therapies against cancer targeting CD38 and TGF-BETA

N° AU2025201957A1

METHODS OF DETERMINING PROTEIN REDUCTION SUSCEPTABILITY

N° MX2025003048A

Methods of determining protein reduction susceptability

N° IL319534A

Cap

N° US2025242114A1

Drug Delivery Device with Drive Sub-Assembly

N° US2025195782A1

Pseudofab-based multispecific binding proteins

N° IL319262A

Polipéptidos que se unen a un epítopo específico del receptor de fc neonatal

N° CO2025001946A2

DEVICE FOR ADMINISTERING A MEDICINAL LIQUID BY INJECTION

N° US2025186700A1

Compuestos de imidazopiridina, preparación de los mismos y usos terapéuticos de los mismos

N° CO2025001849A2

METHOD FOR DETERMINING THE DOSE CAPTURING ACCURACY

N° WO2025172500A1

Compuestos de unión a cx3cr1, métodos y usos de los mismos

N° CO2025001525A2

Treatment of lupus using humanized anti-cxcr5 antibodies

N° IL318907A

METHODS OF TREATING CEACAM5-EXPRESSING CANCERS

N° WO2025169012A1

DATA PROCESSING SYSTEMS AND METHODS FOR IDENTIFYING NEW INDICATIONS FOR DRUGS

N° US2025182862A1

METHODS FOR ETHANOL-FREE MRNA PURIFICATION

N° WO2025163146A1

AUTOMATIC MEMBRANE STAINING QUANTIFICATION

N° WO2025162972A1

NEEDLE SHROUD UNLOCK DEVICE FOR A MEDICAMENT DELIVERY DEVICE

N° WO2025162928A1

PURIFYING DEVICE, SYSTEM AND METHOD FOR PURIFYING A NEEDLE FOR DELIVERING A MEDICAMENT

N° WO2025162927A1

NEEDLE ARRANGEMENT, DRUG DELIVERY DEVICE COMPRISING THE NEEDLE ARRANGEMENT AND METHOD FOR OPERATING THE DRUG DELIVERY DEVICE

N° WO2025162926A1

POLYPEPTIDES BINDING TO A SPECIFIC EPITOPE OF THE NEONATAL FC RECEPTOR

N° MX2025001058A

METHODS FOR ENHANCING ADENO-ASSOCIATED VIRUS (AAV) PRODUCTION

N° WO2025158381A1

ELECTRONIC ADD-ON MODULE WITH A MECHANICAL COUPLING ELEMENT

N° WO2025157883A1

ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE

N° WO2025157890A1

ELECTRONIC ADD-ON MODULE COMPRISING A MICROSWITCH

N° WO2025157884A1

ELECTRONIC ADD-ON MODULE COMPRISING A SENSOR ARRANGEMENT

N° WO2025157886A1

ELECTRONIC ADD-ON MODULE COMPRISING A SENSOR ARRANGEMENT

N° WO2025157892A1

ELECTRONIC ADD-ON MODULE COMPRISING ELECTRICALLY CONDUCTIVE ELEMENTS PROVIDING A SWITCH

N° WO2025157887A1

ELECTRONIC ADD-ON MODULE COMPRISING A SENSOR ARRANGEMENT

N° WO2025157891A1

ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE

N° WO2025157893A1

ELECTRONIC ADD-ON MODULE WITH TRANSMISSION COMPONENT

N° WO2025157888A1

ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE

N° WO2025157885A1

PREDICTING DISEASE SEVERITY

N° WO2025157868A1

AUGMENTING REAL WORLD PATIENT DATA TO INCLUDE PROXY ENDPOINT DATA

N° WO2025157869A1

Polypeptides binding to a specific epitope of the neonatal fc receptor

N° IL318486A

CX3CR1-BINDING COMPOUNDS, USES THEREOF AND RELATED METHODS

N° MX2025000732A

TRICYCLIC COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES AS ERK5 INHIBITORS

N° WO2025153712A1

IMIDAZOPYRIDINE COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF

N° MX2025000659A

Imidazopyridine compounds, preparation thereof and therapeutic uses thereof

N° IL318390A

Cx3cr1-binding compounds, uses thereof and related methods

N° IL318323A

SCALABLE PRODUCTION OF CLOSED-ENDED DNA

N° WO2025149936A1

TRISPECIFIC BINDING PROTEINS, METHODS, AND USES THEREOF

N° US2025250338A1

Dominios variables únicos de inmunoglobulina que se dirigen al receptor de linfocitos t

N° CO2025000062A2

TRISPECIFIC BINDING PROTEINS, METHODS, AND USES THEREOF

N° US2025250337A1

ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE

N° WO2025146464A1

ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE

N° WO2025146466A1

LIPIDS HAVING DENDRITIC MOIETIES

N° WO2025141521A1

OPTICAL CONFIGURATION OF A MEDICAMENT RESERVOIR OF A DRUG DELIVERY DEVICE

N° US2025135120A1

OPTICAL CONFIGURATION OF A MEDICAMENT RESERVOIR OF A DRUG DELIVERY DEVICE

N° US2025121140A1

Anticuerpos anti-bcma

N° CO2024017842A2

Activadores de linfocitos citolíticos naturales (nk) que se unen a las variantes de nkp46 y bcma con genomanipulación de fc

N° CO2024017823A2

SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

N° WO2025141029A1

New peptides as selective il-23 receptor antagonists

N° IL317902A

MALIC AND GLUTARIC ACID BASED IONIZABLE LIPIDS

N° WO2025134071A1

MEDICAMENT DEIVERY SYSTEM, CARTRIDGE AND REUSABLE INJECTOR DEVICE

N° WO2025133224A2

MACHINE LEARNING SYSTEMS AND METHODS TO DIAGNOSE RARE DISEASES

N° US2025118437A1

INGESTIBLE CAPSULE

N° WO2025132748A1

INGESTIBLE CAPSULES AND ASSOCIATED PACKAGING

N° WO2025132747A1

INGESTIBLE CAPSULE

N° WO2025132746A1

A MEDICMENT DELIVEY SYSTEM AND A DRIVE SUB-ASSEMBLY

N° WO2025132683A1

BLINDING DEVICE FOR INJECTING DEVICES

N° WO2025132500A1

MEDICAMENT CONTAINER, INJECTION DEVICE AND METHOD OF FILLING THE SAME

N° WO2025132497A1

A MEDICAMENT DELIVEY SYSTEM

N° WO2025132686A1

INJECTOR DEVICE

N° WO2025132563A1

A MEDICMENT DELIVEY SYSTEM

N° WO2025132685A1

A MEDICMENT DELIVEY SYSTEM AND A DRIVE SUB-ASSEMBLY

N° WO2025132682A1

A MEDICAMENT DELIVERY DEVICE

N° WO2025132624A1

IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING T CELL RECEPTOR

N° MX2024015501A

METHODS AND SYSTEMS FOR SEQUENCE DECONVOLUTION

N° WO2025125601A1

NEW PEPTIDES AS SELECTIVE IL-23 RECEPTOR ANTAGONISTS

N° MX2024015497A

EFFECTORLESS IGG1 FC VARIANTS

N° WO2025125545A1

Highly concentrated antibody compositions

N° IL317686A

CD28/OX40 BISPECIFIC ANTIBODIES

N° US2025215102A1

STOPPER FOR A MEDICAMENT CONTAINER AND MEDICAMENT CONTAINER

N° WO2025125228A1

Immunoglobulin single variable domains targeting t cell receptor

N° IL317588A

Cartridge Assembly for a Drug Delivery Device and Drug Delivery Device

N° US2025099681A1

METHODS FOR PURIFICATION OF MULTI-SPECIFIC ANTIBODIES

N° MX2024015178A

INSULIN CONJUGATES

N° US2025206798A1

Methods for purification of multi-specific antibodies

N° IL317367A

CARTRIDGE ASSEMBLY AND METHOD FOR ASSEMBLING THE SAME

N° US2025090757A1

METHOD FOR DETECTING MICROORGANISMS

N° WO2025114394A1

MULTIFUNCTIONAL NATURAL KILLER (NK) CELL ENGAGER COMBINATION THERAPY FOR TREATING HEMATOLOGICAL NEOPLASTIC DISORDERS

N° WO2025114919A1

MULTIFUNCTIONAL NATURAL KILLER (NK) CELL ENGAGER COMBINATION THERAPY FOR TREATING HEMATOLOGICAL NEOPLASTIC DISORDERS

N° US2025195653A1

PURIFICATION OF CLOSED-ENDED DNA MOLECULES

N° WO2025114932A1

FLUID BARRIER WITH STRIPPING MECHANISM FOR LARGE VOLUME DRUG DELIVERY DEVICE

N° WO2025117534A1

FLUID BARRIER WITH BREAKING RAM FOR LARGE VOLUME DRUG DELIVERY DEVICE

N° WO2025117518A1

Nuevos péptidos como antagonistas selectivos del receptor de la il-23

N° CO2024016062A2

FLUID BARRIER CAP SYSTEM FOR LARGE VOLUME DRUG DELIVERY DEVICE

N° WO2025117520A1

NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKp46 AND BCMA VARIANTS WITH FC-ENGINEERING

N° US2025197528A1